Open access
Oct 2026
Vulnerability index impacts distribution of prostate cancer clinical trials in the United States
Prostate cancer trials are disproportionately concentrated in the US, with lower representation in vulnerable areas, and expanding trial access to underserved areas is a crucial step in promoting equitable access to care.
Vitor Abreu de Góes, Benjamin D. Mercier, Yu-Jun Li et al.
· Frontiers in Oncology · 0 citations